Search bioRxiv⌕ Search

Biology subjects

Dessau, J. L.

Publications and source records attributed to Dessau, J. L..

2 recordsLinked to original sources

An Insoluble De Novo Protein Enables Survival of E. coli by Co-precipitating with a Gene Repressor

De novo proteins that share no ancestry with natural sequences can serve as additions to the evolved proteomes of living cells. Upon expression in cells, these novel proteins can provide biological functions that alter cell viability and growth. To isolate such proteins, we searched a combinatorial library of novel sequences by selecting for sequences that sustain the growth of E. coli under conditions where the recipient cell would otherwise be inviable. This led to the discovery of Resc4 (Rescuer 4), a de novo protein that sustains growth on minimal medium of an E. coli strain harboring a lethal deletion of metC, which encodes cystathionine {beta}-lyase, an essential enzyme in the biosynthesis of methionine. Surprisingly, despite its ability to rescue the deletion of a biosynthetic enzyme, Resc4 is insoluble. Nonetheless, Resc4 sustains the growth of 11metC cells by upregulating expression of metB, which encodes a different enzyme, cystathionine {gamma}-synthase, which has a moonlighting activity that compensates for the deleted activity encoded by metC. Proteomic analysis revealed that Resc4 co-precipitates MetJ, the repressor of the methionine biosynthesis operon. Precipitation of MetJ leads to overproduction of cystathionine {gamma}-synthase, thereby allowing it to rescue the deletion of metC. These results, taken together with previous findings on other de novo proteins, demonstrate that novel proteins added to a cells proteome can perform life sustaining functions, and may shed light on de novo gene birth - both in synthetic biology and in natural evolution.

synthetic biology↗

Epigenetic state determines inflammatory sensing in neuroblastoma

Immunotherapy has revolutionized cancer treatment, but many cancers are not impacted by currently available immunotherapeutic strategies. Here, we investigated inflammatory signaling pathways in neuroblastoma, a classically "cold" pediatric cancer. By testing the functional response of a panel of 20 diverse neuroblastoma cell lines to three different inflammatory stimuli, we found that all cell lines have intact interferon signaling and all but one lack functional cGAS-STING signaling. However, toll-like receptor (TLR) signaling, particularly through TLR3, was heterogeneous. Six cell lines showed robust response, five of which are in the mesenchymal epigenetic state, while all 14 unresponsive cell lines are in the adrenergic state. Genetically switching the adrenergic BE2(c) cell line towards the mesenchymal state fully restored TLR responsiveness. In responsive cells, TLR3 activation results in the secretion of pro-inflammatory cytokines, enrichment of inflammatory transcriptomic signatures, and increased tumor killing by T-cells in vitro. Using single cell RNA sequencing data, we show that human neuroblastoma cells with stronger mesenchymal signatures have a higher basal inflammatory state, demonstrating intra-tumoral heterogeneity in inflammatory signaling that has significant implications for immunotherapeutic strategies in this aggressive childhood cancer.

cancer biology↗